Blog, 2021

ChemDiv shares reviews on Nature and Science Journal articles that we found the most exciting this month. Today we observe Stem cell therapy, Neurophysiology, Physiology, COVID-19, and Molecular biolo...

ChemDiv shares reviews on Nature and Science Journal articles that we found the most exciting this month. Here is the second part of the October reviews. Today we observe Drug Research, Physiology, an...

Epigenetics is a growing and promising area of drug discovery research. To date, efforts in this direction have led to over 100 clinical candidates and seven FDA-approved drugs [1-2]. The main idea be...

Scientists launched regeneration after a heart attack, and healed the heart Almost every tissue in the human body is able to recover from damage, regenerating — growing again. The skin repairs scra...

Gamma-aminobutyric acid (GABA) is familiar to neurophysiologists as an inhibitory neurotransmitter in the central nervous system.

Protein kinase inhibitors are an important class of drugs. The FDA has approved over 70 small molecules with this type of action [1, 2]. Approved kinase inhib...

ChemDiv shares reviews on Nature and Science Journal articles that we found the most exciting this month. Here is the first part of the October reviews. Today we observe Virology, Physiology, and Gene...

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the adult brain. And since everyone, including our brain, needs to relax from time to time for normal work, GABA maintains the...

Here are ChemDiv’s reviews on Nature and Science Journal articles. It is the first part of the August reviews. Today we attract your attention to Drug research, Structural Biology, Physiology, a...